Healthcare Services

Global Nephrotic Syndrome Industry Trends and Market Growth Forecast for 2026–2030

April 2, 2026April 2, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Growth Is Projected For The Nephrotic Syndrome Market During The Forecast Period 2026–2030?

The nephrotic syndrome market has shown rapid expansion in recent years. It is projected to grow from $0.96 billion in 2025 to $1.06 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.6%. The market’s historical growth was driven by a high prevalence of diabetes and hypertension, the reliance on steroids for treatment, insufficient diagnostic awareness, the gradual adoption of dialysis technologies, and an increasing incidence of childhood nephrotic syndrome.

The nephrotic syndrome market is anticipated to experience significant expansion in the coming years. This market is projected to reach $1.58 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.4%. This growth during the forecast period can be primarily ascribed to progress in targeted therapies, the expanding application of precision nephrology, the creation of enhanced dialysis equipment, increased investment in innovations for kidney replacement therapy, and the increasing utilization of molecular diagnostic instruments. Key trends anticipated over the forecast timeframe involve the increasing application of immunosuppressive treatments, a rising demand for sophisticated dialysis and kidney support technologies, wider implementation of early diagnostic screening initiatives, the escalating incidence of chronic kidney diseases necessitating treatment, and the broader integration of personalized medicine strategies within nephrology.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21228&type=smp

Which Economic Or Industry Drivers Are Impacting The Nephrotic Syndrome Market?

A rising occurrence of kidney ailments is anticipated to boost the expansion of the nephrotic syndrome market in the future. Kidney diseases encompass various conditions or disorders that hinder the proper functioning of the kidneys, essential organs tasked with purifying blood by removing waste and excess fluids. This surge in kidney disease cases is linked to factors such as diabetes, high blood pressure, obesity, an aging demographic, and altered lifestyle habits, such as consuming too much sodium and insufficient hydration. Nephrotic syndrome exacerbates kidney issues by damaging the glomeruli, thereby compromising the kidney’s capacity to filter waste and retain vital proteins. For example, in June 2023, data from Oxford Academic, an academic research platform of Oxford University Press located in the UK, indicated that the prevalence of CKD in the UK is estimated to increase by 4% from 8.27 million to 8.61 million individuals between 2022 and 2032. The anticipated stage distribution for 2032 is 30.36% for stage 1, 21.07% for stage 2, 29.78% for stage 3a, 11.86% for stage 3b, 4.15% for stage 4, and 2.78% for stage 5. Consequently, the growing number of kidney disease cases is fueling the expansion of the nephrotic syndrome market.

What Market Segments Are Evaluated Within The Nephrotic Syndrome Market?

The nephrotic syndrome market covered in this report is segmented –

1) By Type: Drugs, Devices

2) By Diagnosis Tests: Urinalysis, Glomerular Filtration Rate (GFR), Blood Test, Kidney Biopsy, Computerized Tomography (CT) Scan

3) By Application: Clinics, Hospitals, Specialty Centres, Other Applications

Subsegments:

1) By Drugs: Steroids, Immunosuppressants, Diuretics, ACE Inhibitors

2) By Devices: Dialysis Machines, Peritoneal Dialysis Catheters, Hemodialysis Catheters, Kidney Replacement Therapy Devices

Which Trends Are Shaping The Future Of The Nephrotic Syndrome Market?

Leading companies operating in the nephrotic syndrome market are prioritizing the development of innovative formulations, such as loop diuretic injections, to enhance fluid management and lessen edema in patients afflicted with nephrotic syndrome. A loop diuretic Injection is defined as an injectable medication that prevents sodium and chloride reabsorption in the loop of Henle, thereby promoting rapid urine production. It finds use in addressing conditions like acute pulmonary edema, heart failure, and severe hypertension by reducing fluid overload. As an illustration, in March 2024, Avenacy Inc., a US-based pharmaceutical company, introduced furosemide for Injection in the U.S., a generic equivalent to Lasix, which received approval from the Food and Drug Administration for treating edema linked to heart failure, liver cirrhosis, and kidney diseases. Packaged in 25-unit packs of 100 mg/10 mL doses, this launch is integral to Avenacy’s broader strategy to expand its injectable medication portfolio, with intentions to unveil over 20 products in 2024. This particular drug is indicated for adult and pediatric patients for the management of edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, including nephrotic syndrome.

Who Are The Top Market Participants Influencing The Nephrotic Syndrome Market?

Major companies operating in the nephrotic syndrome market are Pfizer Inc., F. Hoffmann-La Roche AG, AbbVie Inc., Bristol-Myers Squibb Company, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Amgen Inc., Eli Lilly and Company, Asahi Kasei Corporation, Otsuka Pharmaceutical Co. Ltd., Astellas Pharma Inc., Vertex Pharmaceuticals, Chugai Pharmaceutical Co. Ltd., Mallinckrodt Company, Evotec SE, Travere Therapeutics Inc., Aurinia Pharmaceuticals Inc., Orbis Biosciences Inc., Alpine Immune Sciences, Kezar Life Sciences, Zenyaku Kogyo Co. Ltd

Read the full nephrotic syndrome market report here:

https://www.thebusinessresearchcompany.com/report/nephrotic-syndrome-global-market-report

What Are The Top-Performing Regions Within The Nephrotic Syndrome Market?

North America was the largest region in the nephrotic syndrome market in 2025. The regions covered in the nephrotic syndrome market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Nephrotic Syndrome Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=21228&type=smp

Browse Through More Reports Similar to the Global Nephrotic Syndrome Market 2026, By The Business Research Company

Neonatal Infant Care Global Market Report

https://www.thebusinessresearchcompany.com/report/neonatal-infant-care-global-market-report

Acute Respiratory Distress Syndrome Ards Global Market Report

https://www.thebusinessresearchcompany.com/report/acute-respiratory-distress-syndrome-ards-global-market-report

Lower Respiratory Tract Therapeutics Global Market Report

https://www.thebusinessresearchcompany.com/report/lower-respiratory-tract-therapeutics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795